Key facts
- This page summarizes Rakesh P. Godhani's Form 4 filing for TransMedics Group, Inc. (TMDX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 06 Aug 2021, 17:05.
Rakesh P. Godhani - 04 Aug 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)
- Reporting relationship
- Chief Digital Officer
- Issuer ticker
- TMDX
- Reported as of
- 04 Aug 2021
- Net transaction value
- $0
- Reporting owner signature
- By: /s/ Stephen Gordon, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Rakesh P. Godhani filed Form 4 for TransMedics Group, Inc. (TMDX) on 06 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +140,000
- Change %
- Price
- $0.000000
- Shares after
- 140,000
- Date
- 04 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 140,000
- Exercise price
- $27.87
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vests as to 25% of the shares on the first anniversary of the Vesting Commencement Date, July 29, 2021, and as to the remaining shares in equal monthly installments over three years thereafter.